Bought 500 ITRM @$1.60 Target @$8.00 date Jan 10,2022
Item Therapeutics, Inc
Bought 500 ITRM @$1.60. Target @$8.00 date Jan 10,2022
Buy limit 500 ITRM @$1.40. Target @$10.00 date May 2,2022
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly
differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens.
Company Website: iterumtx.com/
Press Release: iterumtx.com/news/press-releases
FDA Aproval analysis review: youtu.be/EPgkP7wO8h4
Bought 500 ITRM @$1.60. Target @$8.00 date Jan 10,2022
Buy limit 500 ITRM @$1.40. Target @$10.00 date May 2,2022
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly
differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens.
Company Website: iterumtx.com/
Press Release: iterumtx.com/news/press-releases
FDA Aproval analysis review: youtu.be/EPgkP7wO8h4
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.